# A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

> **NCT06685835** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Insmed Incorporated** · enrollment: 214 (actual)

## Conditions studied

- Hidradenitis Suppurativa

## Interventions

- **DRUG:** Brensocatib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06685835
- **Lead sponsor:** Insmed Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-16
- **Primary completion:** 2026-02-12
- **Final completion:** 2026-11-17
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06685835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06685835, "A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06685835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*